Toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett's esophagus, dysplasia and adenocarcinoma

Oncotarget

Volumn 7, Issue 17, 2016, Pages 23658-23667

  Huhta, Heikki ^a,b,c   Helminen, Olli ^a,b,c   Lehenkari, Petri P ^a,b,c   Saarnio, Juha ^a,b,c   Karttunen, Tuomo J ^a,b,c   Kauppila, Joonas H ^a,b,c  

^a UNIVERSITY OF OULU   (Finland)

^b MEDICAL RESEARCH CENTER OULU   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Esophageal adenocarcinoma; Toll like receptor 1; Toll like receptor 2; Toll like receptor 4; Toll like receptor 6

Indexed keywords

TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN; TLR6 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BACTERIAL CELL WALL; BARRETT ESOPHAGUS; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; COLUMNAR EPITHELIUM; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS DYSPLASIA; ESOPHAGUS MUCOSA; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PHASE TRANSITION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCORING SYSTEM; SQUAMOUS EPITHELIUM; UPREGULATION; ADENOCARCINOMA; ESOPHAGUS; ESOPHAGUS TUMOR; FOLLOW UP; LYMPH NODE METASTASIS; METABOLISM; METAPLASIA; MIDDLE AGED; PATHOLOGY; PRECANCER; PROGNOSIS; SECONDARY; SURVIVAL RATE; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; BIOMARKERS, TUMOR; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; METAPLASIA; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROGNOSIS; SURVIVAL RATE; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 6;

EID: 84966573839     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.8151     Document Type: Article

References (27)

1. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol. 2003; 21:335-376.
2. Wells JM, Rossi O, Meijerink M, van Baarlen P. Epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad Sci U S A. 2011; 108:4607-4614.
3. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144:646-674.
4. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med. 2002; 347:1175-1186.
5. Castano-Rodriguez N, Kaakoush NO, Mitchell HM. Pattern-recognition receptors and gastric cancer. Front Immunol. 2014; 5:336.
6. Baghdadi J, Chaudhary N, Pei Z, Yang L. Microbiome, innate immunity, and esophageal adenocarcinoma. Clin Lab Med. 2014; 34:721-732.
7. Takala H, Kauppila JH, Soini Y, Selander KS, Vuopala KS, Lehenkari PP, Saarnio J, Karttunen TJ. Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression. J Innate Immun. 2011; 3:631-638.
8. Sheyhidin I, Nabi G, Hasim A, Zhang RP, Ainiwaer J, Ma H, Wang H. Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma. World J Gastroenterol. 2011; 17:3745-3751.
9. Huhta H, Helminen O, Kauppila JH, Takala H, Metsikko K, Lehenkari P, Saarnio J, Karttunen T. Toll-like receptor expression in the natural history of Barrett mucosa. Virchows Arch. 2015; 467:9-18.
10. Kauppila JH, Karttunen TJ, Saarnio J, Nyberg P, Salo T, Graves DE, Lehenkari PP, Selander KS. Short DNA sequences and bacterial DNA induce esophageal, gastric, and colorectal cancer cell invasion. APMIS. 2013; 121:511-522.
11. Helminen O, Huhta H, Takala H, Lehenkari PP, Saarnio J, Kauppila JH. Karttunen TJ. Increased Toll-like receptor expression indicates esophageal columnar dysplasia. Virchows Arch. 2014; 464:11-18.
12. Kauppila JH, Selander KS. Toll-like receptors in esophageal cancer. Front Immunol. 2014; 5:200.
13. Brameier M, Krings A, MacCallum RM. NucPred-predicting nuclear localization of proteins. Bioinformatics. 2007; 23:1159-1160.
14. Booth CL, Thompson KS. Barrett's esophagus: A review of diagnostic criteria, clinical surveillance practices and new developments. J Gastrointest Oncol. 2012; 3:232-242.
15. Zhang Y, Luo F, Cai Y, Liu N, Wang L, Xu D, Chu Y. TLR1/TLR2 agonist induces tumor regression by reciprocal modulation of effector and regulatory T cells. J Immunol. 2011; 186:1963-1969.
16. Lim DM, Narasimhan S, Michaylira CZ, Wang ML. TLR3-mediated NF-(kappa)B signaling in human esophageal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2009; 297:G1172-1180.
17. Daniell HW. Acid suppressing therapy as a risk factor for Candida esophagitis. Dis Esophagus. 2015. Apr 1. doi: 10.1111/dote.12354. [Epub ahead of print].
18. Jouhi L, Datta N, Renkonen S, Atula T, Makitie A, Haglund C, Ahmed A, Syrjanen S, Grenman R, Auvinen E, Lehtonen S, Hagstrom J. Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma-an in vivo and in vitro study. Tumour Biol. 2015; 36:7755-7764.
19. Li D, Jin Y, Sun Y, Lei J, Liu C. Knockdown of toll-like receptor 4 inhibits human NSCLC cancer cell growth and inflammatory cytokine secretion in vitro and in vivo. Int J Oncol. 2014; 45:813-821.
20. Yang H, Wang B, Wang T, Xu L, He C, Wen H, Yan J, Su H, Zhu X. Toll-like receptor 4 prompts human breast cancer cells invasiveness via lipopolysaccharide stimulation and is overexpressed in patients with lymph node metastasis. PLoS One. 2014; 9:e109980.
21. Wang AC, Ma YB, Wu FX, Ma ZF, Liu NF, Gao R, Gao YS, Sheng XG. TLR4 induces tumor growth and inhibits paclitaxel activity in MyD88-positive human ovarian carcinoma. Oncol Lett. 2014; 7:871-877.
22. Wang Y, Cai J, Zeng X, Chen Y, Yan W, Ouyang Y, Xiao D, Zeng Z, Huang L, Liu A. Downregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virusrelated hepatocellular carcinoma via ERK1/2 signaling. BMC Cancer. 2015; 15:821.
23. Weng H, Deng Y, Xie Y, Liu H, Gong F. Expression and significance of HMGB1, TLR4 and NF-kappaB p65 in human epidermal tumors. BMC Cancer. 2013; 13:311.
24. Verbeek RE, Siersema PD, Ten Kate FJ, Fluiter K, Souza RF, Vleggaar FP, Bus P, van Baal JW. Toll-like receptor 4 activation in Barrett's esophagus results in a strong increase in COX-2 expression. J Gastroenterol. 2014; 49:1121-1134.
25. Thiel A, Mrena J, Ristimaki A. Cyclooxygenase-2 and gastric cancer. Cancer Metastasis Rev. 2011; 30:387-395.
26. Wilson D, Charoensawan V, Kummerfeld SK, Teichmann SA. DBD-taxonomically broad transcription factor predictions: new content and functionality. Nucleic Acids Res. 2008; 36:D88-92.
27. Ilmarinen T, Hagstrom J, Haglund C, Auvinen E, Leivo I, Pitkaranta A, Aaltonen LM. Low expression of nuclear Tolllike receptor 4 in laryngeal papillomas transforming into squamous cell carcinoma. Otolaryngol Head Neck Surg. 2014; 151:785-790.